# MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic Strategies

> **NCT06022341** · NA · NOT_YET_RECRUITING · sponsor: **University Hospital, Angers** · enrollment: 120 (estimated)

## Conditions studied

- Myeloproliferative Neoplasm
- Secondary Leukemia

## Interventions

- **OTHER:** Multiomic characterization
- **OTHER:** In vitro drug screening

## Key facts

- **NCT ID:** NCT06022341
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-10-15
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-09-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06022341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06022341, "MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic Strategies". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT06022341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*